United States · FDA National Drug Code directory
EXPAREL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65250-133_7dd52279-ea2e-4f8c-8e29-8172bc3ed882
- Product NDC
- 65250-133
- Form
- INJECTION, SUSPENSION, LIPOSOMAL
- Composition / generic term
- bupivacaine
- Labeler
- Pacira Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160101
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPIVACAINE — 13.3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 VIAL in 1 CARTON (65250-133-04) / 10 mL in 1 VIAL (65250-133-10) · 65250-133-04
- 10 VIAL in 1 CARTON (65250-133-09) / 10 mL in 1 VIAL (65250-133-10) · 65250-133-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →